Cargando…

Age and CHADS(2) Score Predict the Effectiveness of Renin-Angiotensin System Blockers on Primary Prevention of Atrial Fibrillation

Renin-angiotensin system (RAS) blockers have potential protective effects against atrial fibrillation (AF). The purpose of this study was to determine if patient characteristics and underlying co-morbidities could predict the efficacy of RAS blockers in AF prevention. Patients aged ≥ 45 years with h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hung, Chen-Ying, Hsieh, Yu-Cheng, Li, Cheng-Hung, Huang, Jin-Long, Lin, Ching-Heng, Wu, Tsu-Juey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476091/ https://www.ncbi.nlm.nih.gov/pubmed/26094981 http://dx.doi.org/10.1038/srep11442

Ejemplares similares

Statin Therapy for Primary Prevention of Atrial Fibrillation: Guided by CHADS(2)/CHA(2)DS(2)VASc Score
por: Hung, Chen-Ying, et al.
Publicado: (2014)

Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study
por: Hsieh, Yu-Cheng, et al.
Publicado: (2016)

Mortality prediction using CHADS(2)/CHA(2)DS(2)-VASc/R(2)CHADS(2) scores in systolic heart failure patients with or without atrial fibrillation
por: Chen, Yung-Lung, et al.
Publicado: (2017)

Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation
por: Naccarelli, Gerald V, et al.
Publicado: (2009)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis
por: Ma, Haotian, et al.
Publicado: (2021)

Data for rate versus rhythm control strategy on stroke and mortality in patients with atrial fibrillation
por: Weng, Chi-Jen, et al.
Publicado: (2018)

Renin-angiotensin system blockers and COVID-19
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2021)

The role of the renin–angiotensin system blocking in the management of atrial fibrillation
por: Cliff, Brett, et al.
Publicado: (2012)

The importance of statin therapy in atrial fibrillation patients independent of CHADS-VASc score
por: Akşit, Ercan, et al.
Publicado: (2023)

Angiotensin Receptor Blocker for Stroke Prevention in Atrial Fibrillation: beyond Blood Pressure Lowering?
por: Choi, Eue-Keun
Publicado: (2016)

Inhibition of the renin-angiotensin-aldosterone system prevents and cures atrial fibrillation: An overview of systematic reviews
por: Yu, Zhixiang, et al.
Publicado: (2021)

Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysis
por: Lin, Ting-Tse, et al.
Publicado: (2015)

Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
por: Mancia, Giuseppe, et al.
Publicado: (2020)

Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients
por: Farid fahmy, Sarah, et al.
Publicado: (2023)

Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Patients Following Ablation of Atrial Fibrillation
por: Park, Jeong-Hwan, et al.
Publicado: (2009)

Renin–angiotensin system inhibitors and clinical outcomes in patients with atrial fibrillation and heart failure: a propensity score-matched study from the Chinese Atrial Fibrillation Registry
por: Lin, Jing, et al.
Publicado: (2021)

A nomogram based on CHADS(2) score for predicting atrial fibrillation recurrence after cryoballoon ablation
por: Liu, Yu, et al.
Publicado: (2022)

Ischemic stroke risk factors not included in the CHADS-VASC score in patients with non-valvular atrial fibrillation
por: Le Goff, Laurine, et al.
Publicado: (2023)

Association of Renin-Angiotensin System Blockers With Outcomes in Patients with COVID-19
por: Garg, Aakash, et al.
Publicado: (2020)

Association of Renin-Angiotensin System Blockers with Survival in Patients on Maintenance Hemodialysis
por: Kang, Seok Hui, et al.
Publicado: (2023)

Angiotensin II receptor blockers and cardiovascular protection: Focus on left ventricular hypertrophy regression and atrial fibrillation prevention
por: Cuspidi, Cesare, et al.
Publicado: (2008)

Association between CHADS(2) Score and the Preventive Effect of Statin Therapy on New-Onset Atrial Fibrillation in Patients with Acute Myocardial Infarction
por: Huang, Shao-Sung, et al.
Publicado: (2013)

Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cryoballoon ablation outcomes for paroxysmal atrial fibrillation
por: Al-Seykal, Ibragim, et al.
Publicado: (2022)

Polymorphisms of Renin-Angiotensin-Aldosterone System Gene in Chinese Han Patients with Nonfamilial Atrial Fibrillation
por: Zhao, Li-qun, et al.
Publicado: (2015)

Inflammatory markers in paroxysmal atrial fibrillation and the protective role of renin-angiotensin-aldosterone system inhibitors
por: ROŞIANU, ŞTEFAN HORIA, et al.
Publicado: (2013)

Impact of renin–angiotensin–aldosterone-system inhibitor drugs on mortality in patients with atrial fibrillation and hypertension
por: Xu, Wei, et al.
Publicado: (2022)

Impact of CHADS(2) Score on Neurological Severity and Long-Term Outcome in Atrial Fibrillation-Related Ischemic Stroke
por: Kim, Dohoung, et al.
Publicado: (2012)

Novel Dielectric Coagulometer Identifies Hypercoagulability in Patients with a High CHADS(2) Score without Atrial Fibrillation
por: Hasegawa, Yuki, et al.
Publicado: (2016)

Atrial fibrillation and CHADS(2) score as mortality predictors in young versus elderly patients undergoing coronary angiography
por: Teodorovich, Nicholay, et al.
Publicado: (2017)

Role of the CHADS(2) Score in the Evaluation of Carotid Atherosclerosis in Patients with Atrial Fibrillation Undergoing Carotid Artery Ultrasonography
por: Lin, Le-yu, et al.
Publicado: (2018)

A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors
por: Siragy, Helmy M
Publicado: (2011)

Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin‐angiotensin blockers
por: Heerspink, H. J. L., et al.
Publicado: (2016)

Renin-angiotensin system blockers regulate the metabolism of isolated fat cells in vitro
por: Caminhotto, R de O., et al.
Publicado: (2016)

Renin-angiotensin system blockers and severe acute respiratory syndrome coronavirus 2
por: Lévy, Bernard I., et al.
Publicado: (2020)

In reply— Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Impact of renin-angiotensin system inhibitors and beta-blockers on dental implant stability
por: Saravi, Babak, et al.
Publicado: (2021)

Impact of Renin‐Angiotensin System Blockers on Mortality in Veterans Undergoing Cardiac Surgery
por: Antoniak, Derrick T., et al.
Publicado: (2021)

Effect of renin-angiotensin system blocker on COVID-19 in young patients with hypertension
por: Kuzeytemiz, Mustafa, et al.
Publicado: (2022)

Genetic Variant of the Renin-Angiotensin System and Diabetes Influences Blood Pressure Response to Angiotensin Receptor Blockers
por: Konoshita, Tadashi, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_mi7opo2v4lnuj19ge3c47kq5g7